Abstract
THE cause of the malignant transformation of hematopoietic cells in human chronic myelocytic leukemia is unknown. However, the demonstration of a characteristic and specific chromosomal rearrangement involving chromosomes 9 and 22,1,2 known as the Philadelphia chromosome, has suggested a common causative factor in this disorder. In addition, studies of the Philadelphia chromosome and the X-linked enzyme glucose-6-phosphate dehydrogenase have implied that the origin of chronic myelocytic leukemia is a monoclonal stem cell.3,4 The studies strongly suggested that, in at least some of these patients, the cellular target of malignant transformation is a progenitor with the potential for differentiation into granulocytes,.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 144-147 |
| Number of pages | 4 |
| Journal | New England Journal of Medicine |
| Volume | 301 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jul 19 1979 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Origin of Chronic Myelocytic Leukemia in a Precursor of Pre-B Lymphocytes'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS